"The primary endpoint for the Phase 2 Study measured an absolute change from baseline in inflammatory lesions at week 12. Secondary endpoints included: percent change from baseline in inflammatory lesions; absolute and percent change from baseline in non-inflammatory lesions; andthe proportion of patients achieving at least clear or almost clear and a 2-grade improvement from baseline (IGA Success) on the 5-grade Investigator’s Global Assessment (IGA) scale. Each endpoint was assessed at the end of the 12-week treatment period."
- Forums
- ASX - By Stock
- BOT
- BOT 1503 Study Analysis
BOT 1503 Study Analysis, page-12
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 35.0¢ | $1.825M | 5.021M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 385162 | 36.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 207029 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 328162 | 0.360 |
10 | 722666 | 0.355 |
10 | 807826 | 0.350 |
5 | 290750 | 0.345 |
12 | 1746201 | 0.340 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 227029 | 4 |
0.370 | 84922 | 5 |
0.375 | 475054 | 3 |
0.380 | 458698 | 18 |
0.385 | 191153 | 6 |
Last trade - 10.27am 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |